10.4103/1673-5374.255974 261 LeeJ.ParkS
Ingold I, Aichler M, Yefremova E, Roveri A, Buday K, Doll S et al
I took one shot of the lowest dose of a synthetic GLP-1, and to say I had an adverse reaction would be somewhat of an understatement
These large red blood cells cannot move efficiently from the bone marrow to the bloodstream, resulting in anemia
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Many experts believe this is often due to rapid weight loss and nutritional stress , rather than the medication itself